Key points are not available for this paper at this time.
Primary therapy for Hodgkin lymphoma (HL) is curative in ˜ 85% of patients 1. Randomized phase III and single arm phase II trials have established high dose chemotherapy and autologous hematopoie...
Arai et al. (Fri,) studied this question.